Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2376results about "Acyltransferases" patented technology

Recombinant yarrowia lipolytica capable of efficiently and rapidly producing sclareol as well as construction method and application of recombinant yarrowia lipolytica

PendingCN119351238AFungiMicroorganism based processesKu70Perillyl alcohol
The invention belongs to the technical field of bioengineering, and discloses a recombinant yarrowia lipolytica capable of efficiently and rapidly producing sclareol, which is characterized in that optimized sclareol synthase related coding genes ScLPPS, ScSCS, GGPPS1, GGPPS2, ERG20 and tHMGR coding genes are inserted into a yarrowia lipolytica genome; inserting optimized pentadienol utilization pathway coding genes such as IPK, THIM and IDI coding genes; and inserting an optimized ATP: citrate lyase coding gene ACLY to obtain the ATP: citrate lyase coding gene ACLY. The recombinant yarrowia lipolytica is based on knockout of a yarrowia lipolytica strain responsible for coding a non-homologous recombination gene ku70, so that the homologous recombination capability of the yarrowia lipolytica strain is enhanced, gene integration is realized through the homologous recombination function of the yarrowia lipolytica, the genetic stability of the introduced gene can be greatly improved, and the recombinant yarrowia lipolytica strain has a good application prospect. The construction method of the recombinant yarrowia lipolytica strain is efficient and simple to operate.
Owner:ZHIHE BIOTECHNOLOGY (CHANGZHOU) CO LTD

Guided microbial remodeling, a platform for the rational improvement of microbial species for agriculture

The present disclosure provides guided microbial remodeling (GMR) methods for the rational improvement of plant-associated microbes to perform plant-beneficial functions. The GMR methods described herein allow for non-intergeneric genetic optimization of key regulatory networks within the microbes, which improve plant-beneficial functions over wild-type microbes but don't have the risks associated with transgenic approaches (e.g., unpredictable gene function, public and regulatory concerns, etc.). The present disclosure also provides remodeled microbes and compositions thereof. The utilization of remodeled microbes and compositions thereof will enable farmers to realize more productive and predictable crop yields without the nutrient degradation, leaching, or toxic runoff associated with traditional synthetically derived fertilizers.
Owner:PIVOT BIO INC

Pichia pastoris engineering strain with high yield of sclareol as well as construction method and application of pichia pastoris engineering strain

The invention belongs to the technical application field of microbial metabolic engineering and synthetic biology, and particularly relates to a pichia pastoris engineering strain for high-yield sclareol as well as a construction method and application of the pichia pastoris engineering strain. The method comprises the following steps: constructing a biosynthetic pathway of sclareol in a host strain, and optimizing an intracellular mevalonic acid metabolic pathway and a central metabolic pathway to obtain an engineering strain A; the host strain is pichia pastoris; or overexpressing or knocking out a metabolism regulation factor in the obtained engineering bacterium A to obtain an engineering bacterium strain B; or, in the obtained engineering bacterium B, a synthetic pathway is targeted to peroxisome and optimized by adopting a cell region compartment strategy, and an engineering bacterium strain C is obtained. The invention provides a pichia pastoris chassis cell for synthesizing a diterpenoid sclareol and an engineering strain for synthesizing sclareol. By introducing and optimizing the expression of a sclareol synthesis pathway, the fermentation yields of sclareol in shake flask batch and bioreactor batch fed-batch fermentation are respectively 631.6 mg / L and 10.5 g / L.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Genetically engineered bacterium, preparation method thereof and application of genetically engineered bacterium in synthesis of sclareol

The invention provides a genetically engineered bacterium, a preparation method thereof and application of the genetically engineered bacterium in synthesis of sclareol. The genetically engineered bacterium comprises a CcLPPS gene derived from Cistanus crenatus, and a CcLPPS gene derived from Cistanus crenatus, the genetically engineered bacterium is selected from yarrowia lipolytica. According to the invention, the stably expressed sclareol efficient de novo synthesis strain is constructed, and no organic reagent or any path intermediate substance is added in the whole fermentation process, so that the production cost is greatly reduced, and the subsequent separation and purification steps are simplified. The engineering yarrowia lipolytica strain provided by the invention is high in production intensity and simple in fermentation process, has a relatively good application prospect, and lays a foundation for producing sclareol by a microbial fermentation method.
Owner:TIANJIN ASYMCHEM BIOTECHNOLOGY CO LTD

Increased production of acetyl-phosphate and products derived therefrom in yeasts

PCT designated stage expiredWO2025133860A1Antibody mimetics/scaffoldsHydrolases
The present disclosure concerns a fusion polypeptide for making acetyl-phosphate from glucose, a recombinant yeast host cell expressing the fusion polypeptide as well as methods of using the fusion polypeptide. The fusion polypeptide comprising (i) a glucose-6-phosphate isomerase moiety and (ii) a phosphoketolase moiety.
Owner:DANSTAR FERMENT AG

Wheat E3 ubiquitin ligase gene RFEL1 and application thereof in wheat disease resistance

The invention discloses a wheat E3 ubiquitin ligase gene RFEL1 and application of the wheat E3 ubiquitin ligase gene RFEL1 in wheat disease resistance, and belongs to the technical field of plant genetic engineering. The invention discloses a nucleotide sequence of a wheat E3 ubiquitin ligase gene RFEL1 as shown in SEQ ID NO. 3. The invention further provides application of the wheat E3 ubiquitin ligase gene RFEL1 or related biological materials thereof. The application comprises any one of the following applications: A1, improving the resistance of wheat to stripe rust; a2, the resistance of wheat to powdery mildew is improved; and A3, the resistance of wheat to leaf rust is improved. The E3 ubiquitin ligase RFEL1 gene provided by the invention not only has broad-spectrum resistance to different stripe rust, but also has resistance to wheat leaf rust and powdery mildew. The E3 ubiquitin ligase RFEL1 gene disclosed by the invention is applied to broad-spectrum resistance breeding of wheat and has important application value.
Owner:HENAN AGRICULTURAL UNIVERSITY

Increased production of acetyl-coenzyme a and derived products in yeasts

The present disclosure provides a recombinant yeast host cell having a plurality of native and / or heterologous enzymes that function in an engineered metabolic pathway to convert fructose-6-phosphate to acetyl-coenzyme A. The recombinant yeast host cell can be used, for example, in a process for making acetyl-coenzyme A, acetone and / or isopropanol. The plurality of native and / or heterologous enzymes is activated, upregulated, or overexpressed. The plurality of native and / or heterologous enzymes comprises a phosphoketolase; and optionally an acetate kinase; and / or a phosphotransacetylase. The recombinant yeast host cell comprises at least one of: at least two copies of a heterologous nucleic acid molecule encoding the phosphoketolase; a native and / or heterologous enzyme that functions in an engineered non-oxidative pentose phosphate pathway, wherein the native and / or heterologous enzyme is activated, upregulated, or overexpressed; and / or a native and / or heterologous protein that functions in an engineered metabolic pathway to convert pantothenate into acetyl-coenzyme A, wherein the native and / or heterologous protein is activated, upregulated or overexpressed and comprises at least one of: FEN2 or CAB1.
Owner:DANSTAR FERMENT AG +1

5-aminolevulinic acid synthetase mutant and application thereof

The invention relates to the technical field of synthetic biology and microbial fermentation, in particular to a 5-aminolevulinic acid synthetase mutant and application thereof. According to the invention, 5-aminolevulinic acid synthetase derived from rhodobacter capsulatus is expressed in recombinant Escherichia coli, point mutation is carried out on non-conservative amino acid of wild-type ALAS to obtain I86C mutants, the enzymatic activity of the 5-aminolevulinic acid synthetase is improved, and the ability of the 5-aminolevulinic acid synthetase in synthesis of 5-aminolevulinic acid is improved. The method can be used for solving the problems that the enzyme activity of the ALAS is low and the activity of the ALAS is easily inhibited by high-concentration substrate glycine and the like at present, and the yield of the 5-ALA is increased.
Owner:INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI

Terpenoid production and strain

The invention discloses production of terpenoids and a strain, and belongs to the technical field of bioengineering. The serratia marcescens engineering bacteria for producing the semi-terpenoids or monoterpenoids are constructed, and can be used for producing linalool, isoprene, isopentenol, 1, 3, 4-triterpenes and 1, 3, 4-triterpenes. The composition is prepared from 1, 8-cineole, alpha-pinene, pinene, gamma-terpinene, geraniol, (+)-limonene, (-)-limonene, myrcene, beta-ocimene, sabinene, (-)-alpha-bisabolol, (-)-alpha-bisabolol, longifolene, wallenenes, beta-elemene, farnesene, patchouli alcohol, acyclic terpene and alpha-santalene. In a 30L fermentation tank, the yield of linalool produced by the serratia engineering bacteria is 40.72 g.L <-1 >.
Owner:XI AN ZHUO HONG CHAO YUAN BIOLOGY SCIENCE & TECHNOLOGY CO LTD

Yarrowia lipolytica engineering strain for producing cocoa butter equivalent and construction method and application of Yarrowia lipolytica engineering strain

The invention provides a Yarrowia lipolytica engineering strain for producing cocoa butter equivalent and a construction method and application thereof, and relates to the technical field of biology, the construction method comprises the following steps: inserting an anti-translation PFAD2 promoter into a Yarrowia lipolytica chassis strain to adjust the composition of target fatty acid, so that the contents of palmitic acid and stearic acid are respectively increased to 27.3% and 19.8%; the contents of palmitoleic acid and oleic acid are reduced to 4.5% and 36.8%; the twelve-site fatty acid desaturase gene FAD2 is knocked out, and linoleic acid is completely eliminated; a plant-derived diacylglycerol acyltransferase gene DGAT or phospholipid is introduced; the diacylglycerol acyltransferase gene PDAT is used for synthesizing cocoa butter equivalent (CBE). The yield of cocoa butter equivalent of the constructed yarrowia lipolytica engineering strain finally reaches 1.00 + / -0.09 g / L and accounts for 30% of the total fat content. The technical problem of low cocoa butter equivalent production efficiency of engineering modified yeast in the prior art is solved.
Owner:GUANGDONG TECHNION ISRAEL INST OF TECH

Rice RN85zN-eH and detection method thereof

The invention relates to a nucleic acid molecule of a rice transformation event RN85zN-eH and a detection method. The nucleic acid molecule of the rice RN85zN-eH comprises a sequence shown in SEQ ID NO: 1 or a reverse complementary sequence thereof, or a sequence shown in SEQ ID NO: 2 or a reverse complementary sequence thereof. The rice transformation event RN85zN-eH disclosed by the invention has the characteristics of insect resistance and glufosinate-ammonium herbicide resistance, and the detection method can accurately and quickly identify whether a biological sample contains DNA molecules of the transgenic rice event RN85zN-eH or not.
Owner:HAINAN LIKEN BIOTECHNOLOGY CO LTD +1

Modified seed oil content in soybean

PCT designated stage expiredWO2025049913A1HydrolasesPlant peptidesHorticultureSoya bean
Plants producing seeds and seeds comprising increased oil content are provided. Additionally, methods for generating and using plants and seeds having increased oil content are disclosed.
Owner:PIONEER HI BREED INTERNATIONAL INC

Recombinant pichia pastoris strain with high astaxanthin yield as well as construction method and application of recombinant pichia pastoris strain

PendingCN120682959AFungiMicroorganism based processesPichia pastorisCholine kinase
The invention relates to a recombinant pichia pastoris strain capable of producing astaxanthin at high yield as well as a construction method and application of the recombinant pichia pastoris strain. The recombinant pichia pastoris strain is obtained by expressing ATP (adenosine triphosphate) citrate lyase (ACL) and acetyl-CoA synthase (ACS) or phosphoketolase (PK) and phosphotransacetylase (PTA), choline kinase (CK), inositol polyphosphate kinase (IPK) and vitreoscilla hemoglobin (VHB) in host bacteria. Wherein the host bacterium is a pichia pastoris gene modified strain PP-LC2. The astaxanthin production performance of the recombinant strain is verified on the basis of comparison of precursor supply pathways, IUP pathway construction and improvement of the oxygen supply capacity of the engineering strain, and the astaxanthin production capacity of the pichia pastoris is further improved. The construction method of the recombinant pichia pastoris is simple, the synthesis of astaxanthin can be better promoted, the engineering strain can efficiently synthesize the astaxanthin by utilizing methanol through amplification fermentation of a 5L fermentation tank, and industrial production is facilitated.
Owner:NANJING TECH UNIV

Genetically engineered bacterium for synthesizing N-acetyl blue as well as construction method and application of genetically engineered bacterium

The invention relates to the technical field of dye synthesis, and particularly discloses a genetically engineered bacterium for synthesizing N-acetyl blue as well as a construction method and application of the genetically engineered bacterium. The supply capacity of precursor substances glutamic acid and glutamine of the genetically engineered bacterium is high, the fermentation process is simple, the production intensity of the precursor substances glutamine and N-acetylglutamine is improved by cutting off a consumption path, relieving negative feedback inhibition and enhancing the expression level of key genes through the genetically engineered bacterium, and finally the yield of N-acetylblue reaches 41.2 g / L.
Owner:VERTEXYN (NANJING) BIOWORKS CO LTD

Dual silencing

PendingGB2635479AOrganic active ingredientsSpecial deliveryProprotein Convertase Subtilisin/Kexin 9Single strand
A nucleic acid molecule comprising: i) a first nucleic acid comprising a double stranded inhibitory ribonucleic acid (RNA) molecule comprising a sense and an antisense strand designed with reference to a nucleotide sequence comprising a cardiovascular disease associated gene to be silenced and wherein said cardiovascular gene is proprotein convertase subtilisin kexin 9 (PCSK9) there is provided a single stranded deoxyribonucleic acid (DNA) molecule conjugated to the 5’ end of said sense strand; and ii) a second nucleic acid comprising a double stranded inhibitory ribonucleic acid (RNA) molecule comprising a sense and an antisense strand designed with reference to a different cardiovascular disease associated gene to be silenced wherein said cardiovascular gene is lipoprotein (a) (Lp(a)) and wherein there is provided a single stranded deoxyribonucleic acid (DNA) molecule conjugated to the 5’ end of said sense strand wherein the single stranded deoxyribonucleic acid (DNA) molecule is substantially complementary to the single stranded deoxyribonucleic acid (DNA) molecule set forth in i) above and anneals by complementary base pairing to form a double stranded DNA linker that links the first and second double stranded inhibitory ribonucleic acid (RNA) molecules.
Owner:ARGONAUTE RNA LTD

Recombinant yeast cell having increased pyruvate decarboxylase activity

PendingUS20240409964A1BiofuelsMicroorganism based processesYeastPyruvate decarboxylase activity
The present disclosure provides a recombinant yeast cell for making ethanol. The recombinant yeast cell comprises a first genetic modification to increase an ethanol yield in the recombinant yeast cell when compared to a parental yeast cell. The recombinant yeast cell also comprises a second genetic modification capable of increasing pyruvate decarboxylase activity in the recombinant yeast cell when compared to the parental yeast cell. The parental yeast cell lacks the first genetic modification and the second genetic modification. The present disclosure also provides methods for making the recombinant yeast cell as well processes for using the recombinant yeast cell to make ethanol.
Owner:DANSTAR FERMENT AG

Host cells and methods for improved polyketide production using methylmalonyl-CoA-dependent polyketide synthase (PKS)

The present invention provides for a genetically modified host cell reduced for expression of one of more endogenous enzyme(s) which enable the catabolism of propionyl-CoA and / or methylmalonyl-CoA, and comprising a methylmalonyl-CoA-dependent polyketide synthase (PKS).
Owner:RGT UNIV OF CALIFORNIA

DsRNA nano nucleic acid insecticide for preventing and treating piercing-sucking pests as well as preparation method and application of dsRNA nano nucleic acid insecticide

The invention discloses a dsRNA nano nucleic acid insecticide for preventing and treating piercing-sucking pests, the dsRNA nano nucleic acid insecticide is composed of dsRNA of a specific targeting piercing-sucking pest Chs gene and a carrier, the piercing-sucking pests are Panonychus citri, Diaphorina citri or Aphis gossypii, the nucleotide sequences of the Chs gene are respectively shown as SEQ ID NO.1, SEQ ID NO.2 and SEQ ID NO.3, and the carrier is MgAl or MgFe layered double-metal hydroxide nanoparticles. The dsRNA nano nucleic acid insecticide is applied to host plants of the piercing-sucking pests, after the plants induce the piercing-sucking pests to eat the dsRNA nano nucleic acid insecticide, RNA synthesis and silent Chs genes are interfered in vivo, death is promoted, and the dsRNA nano nucleic acid insecticide has good application prospects in treatment of the piercing-sucking pests.
Owner:HUAZHONG AGRI UNIV

Construction method and application of genetically engineered bacterium for efficiently producing O-acetyl-L-homoserine

The invention relates to the technical field of microbial metabolism engineering, in particular to a construction method and application of genetically engineered bacteria for efficiently producing O-acetyl-L-homoserine. The construction method specifically comprises the following steps: (1) taking a strain Escherichia coli W3110 as a chassis, and knocking out a homoserine O-succinyl transferase coding gene metA; (2) knocking out a gamma-cystathionine synthetase encoding gene metB; (3) knocking out a cysteine lyase coding gene metC; (4) carrying out weakening expression on an O-acetyl-L-homoserine thiolase coding gene metYcm from the marine cyclobacterium; (5) overexpressing a ribulose diphosphate carboxylase coding gene rbcLSse from the synechococcus elongate; (6) overexpressing a ribulose phosphate kinase coding gene prkse from the synechococcus slender; and (7) weakening the expression of the citrate synthase coding gene gltA to obtain the genetically engineered bacterium for efficiently producing the O-acetyl-L-homoserine. The strain provided by the invention is used for producing O-acetyl-L-homoserine, and has the advantages of high yield, high yield and high sugar-acid conversion rate.
Owner:ZHEJIANG UNIV OF TECH

Yarrowia lipolytica strain for synthesizing (2S)-naringenin and application of Yarrowia lipolytica strain

The invention discloses a Sarcabomyces lipolytica strain for synthesizing (2S)-naringenin and application of the Sarcabomyces lipolytica strain, and belongs to the technical field of engineering and bioengineering. According to the invention, a key enzyme CHS is subjected to semi-rational transformation, so that the yield of the strain (2S)-naringenin expressing the mutant V196A / T132C is increased by 60%. According to the method, the modified CHS is further integrated into a yeast genome, conversion of p-coumaric acid to (2S)-naringenin is promoted by strengthening a shikimic acid pathway and enhancing supply of cofactors, so that the yield of the (2S)-naringenin reaches 776mg / L after the constructed strain is fermented in a 24-pore plate for 96 hours, and the yield of the constructed strain can reach 8.65 g / L after the strain is fermented in a 5L fermentation tank; the method lays a foundation for the subsequent biosynthesis of flavonoid compounds, and has potential value and significance for the development of synthetic biology.
Owner:JIANGNAN UNIV

Non-plant host cells producing hyoscyamine alkaloids (ta) and methods of making and using same

Provided herein, inter alia, is an engineered non-plant cell that produces a hyoscyamine alkaloid product, a precursor of a hyoscyamine alkaloid product, or a derivative of a hyoscyamine alkaloid product. Also described is a method for producing a scopolamine alkaloid, a precursor of a scopolamine alkaloid product, or a derivative of a scopolamine alkaloid product using a cell.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Corynebacterium glutamicum for producing N-acetylglucosamine and application of corynebacterium glutamicum

The invention discloses corynebacterium glutamicum for producing N-acetylglucosamine and application of the corynebacterium glutamicum, and belongs to the technical field of synthetic biology. Specifically, the corynebacterium glutamicum overexpresses a GNA1 gene from a brewer's yeast S288C controlled by a tacM promoter, a glmS gene from corynebacterium glutamicum S9114 and a yqab gene from escherichia coli K12 MG1655, and simultaneously has five gene defect types of nagA, nagB, ldhA, msccg and msccg2 in a genome and two gene single base mutation types of odhA and glnA, and the codon of the glnA for coding the 405th amino acid is mutated from TAC to TTC. By blocking excretion of glutamic acid of corynebacterium glutamicum and enhancing conversion of glutamic acid to glutamine, the supply capacity of a precursor of corynebacterium glutamicum is enhanced, and an optimal way for synthesizing N-acetylglucosamine is obtained, so that efficient production of N-acetylglucosamine in corynebacterium glutamicum is realized, and the yield of N-acetylglucosamine in corynebacterium glutamicum is increased. The method has important economic value and social significance.
Owner:SHANDONG RUNDE BIOTECH CO LTD +1

Emodin anthraquinone high-yield engineering strain

The invention discloses an emodin anthraquinone high-yield engineering strain. According to the invention, mdpG and mdpF genes of aspergillus nidulans are exogenous introduced into a chassis strain aspergillus nidulans LO8030, so that the genetically engineered bacterium for producing emodin is obtained. Furthermore, the g1234 gene is knocked out from the genetically engineered bacterium for producing the emodin, so that the yield of the emodin can be obviously improved. The decarboxylase gene is further introduced in an exogenous manner, so that the yield of the emodin can be further remarkably improved. And on the basis, exogenous introduction of mdpK, mdpC and mdpB genes is carried out, such that the chrysophanol-producing genetically engineered bacterium is obtained. Or the rugG gene from talaromyces sp.YE3016 is introduced in an exogenous manner, so that the genetically engineered bacterium for producing the muscardine hydrochloride is obtained.
Owner:ZHEJIANG UNIV +1

L-valine production strain as well as construction method and application thereof

PendingCN120738083ABacteriaMicroorganism based processesHeterologousValine metabolism
The invention relates to an L-valine production strain as well as a construction method and application thereof, the strain is obtained by transformation through a metabolic synthesis path of L-valine, and the construction method comprises the following steps: by taking Cornebacterium glutamicum ATCC 13032 (C.glutamicum) as an original strain, carrying out editing transformation such as gene knockout, gene overexpression, gene heterologous expression, gene double-copy expression and the like on a genome of the original strain by utilizing a metabolic engineering means. The L-valine production strain disclosed by the invention can be used for synthesizing L-valine from the beginning by taking glucose as a carbon source, has the advantages of high production rate, short fermentation period, high strain stability and low cost, and lays a foundation for realizing large-scale production of L-valine. According to the fermentation tank fermentation method, the L-valine is produced in a mechanical stirring type fermentation tank by using the L-valine production strain Va1-09, 86.4 g / L of L-valine is produced by fermenting for 36 hours, and the method has a good industrial prospect.
Owner:JIANGSU YUANYIBANG BIOTECHNOLOGY CO LTD

High-throughput screening methods to identify small molecule targets

Provided herein are methods for identifying pairs of protein binding partners, mutations of which may inform the discovery of pharmaceutically useful small molecules. The methods disclosed herein may allow for the adaptation of the native protein degradation system to modulate specific disease targets at the protein level, in particular, for targets that have long been considered undruggable.
Owner:A ALPHA BIO INC

Genetically engineered bacterium for producing L-arginine as well as construction method and application of genetically engineered bacterium

PendingCN119320737AImproves the ability to accumulate L-arginineincrease production capacityCarbon-nitrogen lyasesBacteriaEscherichia coliGenetic enhancement
The invention relates to the technical field of genetic engineering, and discloses a genetically engineered bacterium for producing L-arginine as well as a construction method and application of the genetically engineered bacterium. Escherichia coli is taken as a starting strain, and the following treatment is performed: overexpressing genes gdhA and gdh of glutamate dehydrogenase, promoting generation of glutamic acid, overexpressing and coding arginine transporter gene argO to enhance extracellular transport of arginine, introducing exogenous argJ to replace a linear synthesis pathway in large intestines, improving the utilization rate of acetyl coenzyme A and accelerating the synthesis efficiency of arginine; a glutamine synthetase gene glnA is over-expressed, and glutamine synthesis is enhanced; the pckA is overexpressed to promote ATP synthesis; meanwhile, speA and adiA genes for coding the arginine decarboxylase are deleted, so that further synthesis of putrescine from L-arginine is inhibited, and the L-arginine accumulation capability of the strain is improved. Through the combined action of the treatment, a genetically engineered bacterium with extremely high L-arginine production yield is finally obtained, and the shake flask fermentation yield can reach 13.7 g / L.
Owner:ZHEJIANG UNIV OF TECH

Recombinant escherichia coli strain for producing 1, 3-butanediol from glucose and method for producing 1, 3-butanediol by using recombinant escherichia coli strain

The present invention relates to a recombinant Escherichia coli strain for producing 1, 3-butanediol from glucose and a method for producing 1, 3-butanediol by using the same, in which a recombinant Escherichia coli strain is developed in which a gene of a pathway required for biosynthesis of 1, 3-BDO from acetyl-CoA is cloned, and removing genes interfering with the pathway or a pathway competing with the pathway. Furthermore, a strain of Escherichia coli has been developed in which the pathways and genes involved in the conversion of glucose to acetyl-CoA, the rate of regeneration of NADPH used as a cofactor, and the effective utilization of the TCA cycle pathway are modified and optimized, which are necessary to improve the biosynthesis efficiency of 1, 3-BDO. Therefore, the recombinant Escherichia coli strain of the present invention can produce 1, 3-butanediol from glucose at high concentration, high yield, and high rate.
Owner:ACTIVON CO LTD

E3 ubiquitin enzyme mutant, modification and protein targeted degradation system thereof and application of E3 ubiquitin enzyme mutant

The invention discloses an E3 ubiquitin enzyme mutant as well as modification and a protein targeted degradation system and application thereof, and particularly relates to a series of targeted protein degradation enhanced E3 ubiquitin enzymes (Trim21-N) and a modification method thereof, the E3 ubiquitin enzymes (Trim21-N) are obtained by modifying a wild type Trim21 (wtTrim21) protein structural domain, and the E3 ubiquitin enzymes comprise Trim21-a, Trim21-b, Trim21-c, Trim21-d, Trim21-e and Trim21-f. The efficiency of degrading the target protein through the ubiquitin proteasome is remarkably improved, and the method has the characteristics of strong endogenous and exogenous universality, high specificity, ubiquitin proteasome dependence, low cytotoxicity, strong cell compatibility and the like on the degradation of the target protein. The invention provides E3 ubiquitin enzyme (Trim21-N) based on a targeted protein degradation enhancement version and an exogenous fluorescence report degradation system of the E3 ubiquitin enzyme (Trim21-N), preferably Trim21-e with the optimal degradation effect, and the E3 ubiquitin enzyme (Trim21-N) is named as delta Trim21. The invention further provides an endogenous protein degradation system based on the delta Trim21. The method has the characteristics of high specificity, rapidness and small module, so that the method can be used for researching various biological and disease mechanisms, including the fields of cell targeted therapy, cell mechanism exploration, genetic engineering and the like.
Owner:EAST CHINA NORMAL UNIV